Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 196 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

NCT07531095

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • New York University Cancer Institute New York, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • Next Virginia Fairfax, Virginia, United States
  • Adana Sehir Egitim ve Arastirma Hastanesi Adana, Turkey (Türkiye)
View Trial Details
Recruiting

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

NCT07099898

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • GSK Investigational Site Mar del Plata, Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aire, Argentina
  • GSK Investigational Site Ciudad Autonoma de Buenos Aire, Argentina
View all 120 locations
View Trial Details
Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

NCT07278479

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • United Theranostics Glen Burnie, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • United Theranostics Princeton, New Jersey, United States
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

NCT05363280

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Siteman Cancer Center, Washington University St Louis, Missouri, United States
View Trial Details

Related conditions